//--> //--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~isPartOf:"The European journal of health economics : HEPAC ; health economics in prevention and care"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject_exact:"Kosten-Nutzen-Analyse"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Kosten-Nutzen-Analyse
67
Cost-benefit analysis
66
Gesundheitsökonomik
28
Health economics
28
Cost-effectiveness analysis
27
Kosten-Wirksamkeits-Analyse
27
Gesundheitskosten
21
Health care costs
21
Lebensqualität
13
Quality of life
13
Theorie
13
Theory
13
Gesundheitswesen
11
Health care system
11
Deutschland
10
Germany
10
Gesundheitsversorgung
10
Großbritannien
10
Health care
10
United Kingdom
10
Disease
9
Krankheit
9
Cost-effectiveness
8
Cost-utility analysis
7
Arzneimittel
6
Economic evaluation
6
France
6
Frankreich
6
Pharmaceuticals
6
Gesundheit
5
Health
5
Mortality
5
Social costs
5
Soziale Kosten
5
Sterblichkeit
5
Willingness to pay
5
Zahlungsbereitschaftsanalyse
5
Cancer
4
Gesundheitsvorsorge
4
Krebskrankheit
4
more ...
less ...
Online availability
All
Undetermined
32
Type of publication
All
Article
65
Book / Working Paper
2
Type of publication (narrower categories)
All
Article in journal
66
Aufsatz in Zeitschrift
66
Collection of articles of several authors
2
Sammelwerk
2
Aufsatzsammlung
1
Case study
1
Fallstudie
1
more ...
less ...
Language
All
English
67
German
1
Author
All
Brouwer, Werner B. F.
2
Drummond, Michael F.
2
Greiner, Wolfgang
2
Iezzi, Angelo
2
Oliva, Juan
2
Peacock, Stuart J.
2
Aas, Eline
1
Achana, Felix
1
Anaya Longaric, Pablo Andrés
1
Anderson, Philippa M.
1
Aranda-Reneo, I.
1
Arrieta, Oscar
1
Attema, Arthur Ewoud
1
Augustin, Matthias
1
Ayyagari, Rajeev
1
Baal, Pieter van
1
Banai, János
1
Barber, Beth
1
Bateman, Eric D.
1
Benrimoj, Shalom I.
1
Berden, Caroline
1
Bergman, Annika
1
Biermann-Stallwitz, Janine
1
Bilir, S. Pinar
1
Black, Christopher M.
1
Blanc, Anne-Sandrine
1
Blome, Christine
1
Borse, Rebekah H.
1
Botteman, M. F.
1
Boulenger, Stephanie
1
Boye, K. S.
1
Brandt, Patricia
1
Braun, Ada
1
Brazier, John E.
1
Breyer, Friedrich
1
Briggs, Andrew Harvey
1
Brodszky, Valentin
1
Buxton, Martin
1
Cabasés Hita, Juan Manuel
1
Cairns, John A.
1
more ...
less ...
Published in...
All
The European journal of health economics : HEPAC ; health economics in prevention and care
Ecological economics : the transdisciplinary journal of the International Society for Ecological Economics
152
Journal of benefit-cost analysis : JBCA
152
NBER working paper series
120
Working paper / National Bureau of Economic Research, Inc.
105
NBER Working Paper
97
Europäische Hochschulschriften / 5
85
Discussion paper series / IZA
73
Environmental & resource economics : the official journal of the European Association of Environmental and Resource Economists
68
Working paper
64
CESifo working papers
57
SpringerLink / Bücher
51
American journal of agricultural economics
50
Discussion paper / Centre for Economic Policy Research
41
Journal of environmental economics and management : JEEM ; the official journal of the Association of Environmental and Resource Economists
41
Policy research working paper : WPS
41
Land economics : applied research on environmental resources
39
Journal of health economics
36
Discussion paper / Tinbergen Institute
35
IZA Discussion Papers
35
The European journal of health economics
35
Discussion paper
33
Energy policy
31
IZA Discussion Paper
31
Research in transportation economics
30
CESifo Working Paper
28
Gabler Edition Wissenschaft
26
Health economics review
26
Discussion paper / International Transport Forum
24
Edward Elgar E-Book Archive
24
Journal of environmental economics and policy
23
Review of environmental economics and policy
23
ZEW discussion papers
23
Applied economics
22
CESifo Working Paper Series
22
IRB-Literaturauslese
22
Umeå economic studies
22
Cambridge working papers in economics
21
Nota di Lavoro
21
Journal of public economics
20
more ...
less ...
Source
All
ECONIS (ZBW)
67
Showing
1
-
50
of
67
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis
Svedbom, Axel
;
Dalén, Johan
;
Ivergård, Moa
;
Borse, …
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
1
,
pp. 45-54
Persistent link: https://www.econbiz.de/10012221637
Saved in:
2
A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction
Hansen, Svenn Alexander
;
Aas, Eline
;
Solli, Oddvar
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
1
,
pp. 73-84
Persistent link: https://www.econbiz.de/10012221639
Saved in:
3
Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France
Tremblay, Gabriel
;
Cariou, Clemence
;
Recher, Christian
; …
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
4
,
pp. 543-555
Persistent link: https://www.econbiz.de/10012421463
Saved in:
4
Is the whole larger than the sum of its parts? : impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials
Michalowsky, Bernhard
;
Hoffmann, Wolfgang
;
Kennedy, Kevin
; …
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
5
,
pp. 717-728
Persistent link: https://www.econbiz.de/10012422019
Saved in:
5
Cost-effectiveness of biennial screening for diabetes related retinopathy in people with type 1 and type 2 diabetes compared to annual screening
Thomas, Rebecca L.
;
Winfield, Thomas G.
;
Prettyjohns, …
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
7
,
pp. 993-1002
Persistent link: https://www.econbiz.de/10012489902
Saved in:
6
Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system
Lee, Tsung-Ying
;
Chen, Hsuan-Ying
;
Chen, Sin-Syue
; …
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
7
,
pp. 1105-1116
Persistent link: https://www.econbiz.de/10012490416
Saved in:
7
Costs and where to find them : identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy
Pöhlmann, J.
;
Norrbacka, K.
;
Boye, K. S.
;
Valentine, W. J.
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
8
,
pp. 1179-1196
Persistent link: https://www.econbiz.de/10012490508
Saved in:
8
Costs and benefits of interventions aimed at major infectious disease threats : lessons from the literature
Kellerborg, Klas
;
Brouwer, Werner B. F.
;
Baal, Pieter van
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
9
,
pp. 1329-1350
Persistent link: https://www.econbiz.de/10012491063
Saved in:
9
How relevant are social costs in economic evaluations? : the case of Alzheimer's disease
Peña-Longobardo, L. M.
;
Rodríguez-Sánchez, B.
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
8
,
pp. 1207-1236
Persistent link: https://www.econbiz.de/10012221328
Saved in:
10
Health state utility values (QALY weights) for Huntington's disease : an analysis of data from the European Huntington's Disease Network (EHDN)
Hawton, Annie
;
Green, Colin
;
Goodwin, Elizabeth
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
9
,
pp. 1335-1347
Persistent link: https://www.econbiz.de/10012221373
Saved in:
11
Patient and general population values for luminal and perianal fistulising Crohn's disease health states
Rencz, Fanni
;
Stalmeier, Peep F. M.
;
Péntek, Márta
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
),
pp. S91-S100
Persistent link: https://www.econbiz.de/10012060934
Saved in:
12
Estimating the marginal cost of a life year in Sweden's public healthcare sector
Siverskog, Jonathan
;
Henriksson, Martin
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
5
,
pp. 751-762
Persistent link: https://www.econbiz.de/10012061272
Saved in:
13
Health-related quality of life measured with the EQ-5D-5L : estimation of normative index values based on a representative German population sample and value set
Grochtdreis, Thomas
;
Dams, Judith
;
König, Hans-Helmut
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
6
,
pp. 933-944
Persistent link: https://www.econbiz.de/10012061329
Saved in:
14
Structured physiotherapy including a work place intervention for patients with neck and/or back pain in primary care : an economic evaluation
Saha, Sanjib
;
Grahn, Birgitta
;
Gerdtham, Ulf-G.
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
2
,
pp. 317-327
Persistent link: https://www.econbiz.de/10012004878
Saved in:
15
Methodological problems in the method used by IQWiG within early benefit assessment of new pharmaceuticals in Germany
Herpers, Matthias
;
Dintsios, Charalabos-Markos
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
1
,
pp. 45-57
Persistent link: https://www.econbiz.de/10011998030
Saved in:
16
Impact of mapped EQ-5D utilities on cost-effectiveness analysis : in the case of dialysis treatments
Yang, Fan
;
Devlin, Nancy
;
Luo, Nan
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
1
,
pp. 99-105
Persistent link: https://www.econbiz.de/10011998056
Saved in:
17
A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
Zimovetz, Evelina A.
;
Joseph, Alain
;
Ayyagari, Rajeev
; …
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
1
,
pp. 21-35
Persistent link: https://www.econbiz.de/10011945849
Saved in:
18
A methodological framework for assessing agreement between cost-effectiveness outcomes estimated using alternative sources of data on treatment costs and effects for trial-based ec...
Achana, Felix
;
Petrou, Stavros
;
Khan, Kamran
;
Gaye, Amadou
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
1
,
pp. 75-86
Persistent link: https://www.econbiz.de/10011945892
Saved in:
19
The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States : relationship to cost‑effectiveness analysis and...
Ghabri, Salah
;
Mauskopf, Josephine
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
2
,
pp. 173-175
Persistent link: https://www.econbiz.de/10011946183
Saved in:
20
A cost-benefit analysis of the immunisation of children against respiratory syncytial virus (RSV) using the English Hospital Episode Statistics (HES) data set
Thomas, Gareth
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
2
,
pp. 177-187
Persistent link: https://www.econbiz.de/10011946186
Saved in:
21
Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom
Wilson, Michele R.
;
Bergman, Annika
;
Chevrou-Severac, Helene
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
2
,
pp. 229-240
Persistent link: https://www.econbiz.de/10011946252
Saved in:
22
New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year
Attema, Arthur Ewoud
;
Krol, Marieke
;
Exel, N. J. A. van
; …
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
2
,
pp. 277-291
Persistent link: https://www.econbiz.de/10011946376
Saved in:
23
Incorporating equity in economic evaluations : a multi-attribute equity state approach
Round, Jeff
;
Paulden, Mike
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
4
,
pp. 489-498
Persistent link: https://www.econbiz.de/10011947051
Saved in:
24
The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England
Meng, Yang
;
Hertel, Nadine
;
Ellis, John
;
Morais, Edith
; …
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
8
,
pp. 1163-1172
Persistent link: https://www.econbiz.de/10011948237
Saved in:
25
Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy : a decision analytic modelling approach
Richter, Ann-Kathrin
;
Klimek, Ludger
;
Merk, Hans
; …
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
9
,
pp. 1229-1242
Persistent link: https://www.econbiz.de/10011948298
Saved in:
26
People's perception and cost-effectiveness of home confinement during an influenza pandemic : evidence from the French case
Orset, Caroline
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
9
,
pp. 1335-1350
Persistent link: https://www.econbiz.de/10011948350
Saved in:
27
Four years of early benefit assessment of new drugs in Germany : a qualitative study on methodological requirements for quality of life data
Blome, Christine
;
Augustin, Matthias
;
Metin, Hidayet
; …
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
2
,
pp. 181-193
Persistent link: https://www.econbiz.de/10011867761
Saved in:
28
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Wehler, Elizabeth
;
Zhao, Zhongyun
;
Bilir, S. Pinar
; …
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
1
,
pp. 49-58
Persistent link: https://www.econbiz.de/10011867984
Saved in:
29
Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients
Malet-Larrea, Amaia
;
Goyenechea, Estíbaliz
; …
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
9
,
pp. 1069-1078
Persistent link: https://www.econbiz.de/10011869543
Saved in:
30
Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin-paclitaxel
Arrieta, Oscar
;
Anaya Longaric, Pablo Andrés
; …
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
7
,
pp. 855-863
Persistent link: https://www.econbiz.de/10011654791
Saved in:
31
Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease : a review of methods used in the literature
Epstein, David
;
García-Mochón, Leticia
;
Kaptoge, Stephen
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
8
,
pp. 1041-1053
Persistent link: https://www.econbiz.de/10011660167
Saved in:
32
Economic valuation and determinants of informal care to people with Alzheimer’s disease
Peña-Longobardo, Luz María
;
Oliva, Juan
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
5
,
pp. 507-515
Persistent link: https://www.econbiz.de/10011299216
Saved in:
33
Costs and benefits of home care for the elderly versus residential care : a comparison using propensity scores
Kok, Lucy
;
Berden, Caroline
;
Sadiraj, Klarita
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
2
,
pp. 119-131
Persistent link: https://www.econbiz.de/10011299560
Saved in:
34
Impact of small study bias on cost-effectiveness acceptability curves and value of information analyses
Müller, Dirk
;
Pullenayegum, Eleanor
;
Gandjour, Afschin
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
2
,
pp. 219-223
Persistent link: https://www.econbiz.de/10011300381
Saved in:
35
Differences in EQ-5D-3L health state valuations among patients with musculoskeletal diseases, health care professionals and healthy volunteers
Schwalm, Anja
;
Feng, You-Shan
;
Moock, Jörn
;
Kohlmann, …
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
8
,
pp. 865-877
Persistent link: https://www.econbiz.de/10011483686
Saved in:
36
Orphan drugs policies : a suitable case for treatment ; editorial
Drummond, Michael F.
;
Towse, Adrian
- In:
The European journal of health economics : HEPAC ; …
15
(
2014
)
4
,
pp. 335-340
Persistent link: https://www.econbiz.de/10010360871
Saved in:
37
Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer : a systematic review and critique
Parkinson, Bonny
;
Pearson, Sallie-Anne
;
Viney, Rosalie
- In:
The European journal of health economics : HEPAC ; …
15
(
2014
)
1
,
pp. 93-112
Persistent link: https://www.econbiz.de/10010235891
Saved in:
38
Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom
Samyshkin, Yevgeniy
;
Kotchie, Robert W.
;
Mörk, Ann-Christin
- In:
The European journal of health economics : HEPAC ; …
15
(
2014
)
1
,
pp. 69-82
Persistent link: https://www.econbiz.de/10010235895
Saved in:
39
Health state utilities for skeletal-related events secondary to bone metastases
Matza, Louis S.
;
Chung, Karen
;
Van Brunt, Kate
; …
- In:
The European journal of health economics : HEPAC ; …
15
(
2014
)
1
,
pp. 7-18
Persistent link: https://www.econbiz.de/10010235900
Saved in:
40
Economic evaluation of nurse-led intensive care follow-up programmes compared with standard care : the PRaCTICaL trial
Hernández, R. A.
;
Jenkinson, D.
;
Vale, L.
; …
- In:
The European journal of health economics : HEPAC ; …
15
(
2014
)
3
,
pp. 243-252
Persistent link: https://www.econbiz.de/10010347783
Saved in:
41
Economic evaluations of homeopathy : a review
Viksveen, Petter
;
Dymitr, Zofia
;
Simoens, Steven
- In:
The European journal of health economics : HEPAC ; …
15
(
2014
)
2
,
pp. 157-174
Persistent link: https://www.econbiz.de/10010255482
Saved in:
42
Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain
Hidalgo Vega, Alvaro
;
Ramos-Goñi, Juan Manuel
; …
- In:
The European journal of health economics : HEPAC ; …
15
(
2014
)
9
,
pp. 917-925
Persistent link: https://www.econbiz.de/10010478210
Saved in:
43
Valuing EQ-5D using Time Trade-Off in France
Chevalier, Julie
;
Pouvourville, Gérard de
- In:
The European journal of health economics : HEPAC ; …
14
(
2013
)
1
,
pp. 57-66
Persistent link: https://www.econbiz.de/10009701621
Saved in:
44
Towards a social discount rate for the economic evaluation of health technologies in Germany : an exploratory analysis
Schad, Mareike
;
John, Jürgen
- In:
The European journal of health economics : HEPAC ; …
13
(
2012
)
2
,
pp. 127-144
Persistent link: https://www.econbiz.de/10009521463
Saved in:
45
Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic : a cost-utility analysis comparing meropenem with piperacillin/tazobactam
Edwards, Steven J.
;
Wordsworth, Sarah
;
Clarke, Mike J.
- In:
The European journal of health economics : HEPAC ; …
13
(
2012
)
2
,
pp. 181-192
Persistent link: https://www.econbiz.de/10009522266
Saved in:
46
Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy
Zaniolo, O.
;
Iannazzo, S.
;
Pradelli, L.
;
Miravitlles, M.
- In:
The European journal of health economics : HEPAC ; …
13
(
2012
)
1
,
pp. 71-80
Persistent link: https://www.econbiz.de/10009491159
Saved in:
47
The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD) : the importance of the comparator
Neyt, Mattias
;
Van Den Bruel, Ann
- In:
The European journal of health economics : HEPAC ; …
13
(
2012
)
4
,
pp. 379-380
Persistent link: https://www.econbiz.de/10009562149
Saved in:
48
Severity as an independent determinant of the social value of a health service
Richardson, Jeff R. J.
;
McKie, John
;
Peacock, Stuart J.
; …
- In:
The European journal of health economics : HEPAC ; …
12
(
2011
)
2
,
pp. 163-174
Persistent link: https://www.econbiz.de/10008906673
Saved in:
49
Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma : application to Fran...
Botteman, M. F.
;
Meijboom, M.
;
Foley, I.
;
Stephens, J. M.
; …
- In:
The European journal of health economics : HEPAC ; …
12
(
2011
)
6
,
pp. 575-588
Persistent link: https://www.econbiz.de/10009376896
Saved in:
50
What values do the public want their health care systems to use in evaluating technologies?
Buxton, Martin
;
Chambers, James D.
- In:
The European journal of health economics : HEPAC ; …
12
(
2011
)
4
,
pp. 285-288
Persistent link: https://www.econbiz.de/10009238266
Saved in:
1
2
Next
Last
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->